Presentation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction

被引:17
作者
Nightingale, AK
Blackman, DJ
Ellis, GR
Schmitt, M
Morris-Thurgood, JA
Jones, EA
Frenneaux, MP
机构
[1] Univ Wales Coll Med, Wales Heart Res Inst, Dept Cardiol, Cardiff CF14 4XN, S Glam, Wales
[2] Univ Wales Hosp, Dept Med Phys & Clin Engn, Cardiff CF4 4XW, S Glam, Wales
关键词
D O I
10.1016/S0735-1097(01)01142-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The goal of this study was to assess whether endothelial dysfunction occurs in the forearm venous capacitance bed of patients with chronic heart failure (CHF) and to determine the role of nitric oxide (NO) in modulating venous tone. BACKGROUND Control of venous tone is crucially important in CHF. More than 70% of blood volume lies in thr venous capacitance beds. Therefore, small changes in venous tone may markedly affect cardiac filling pressures and cardiac output. METHODS Venous tone was measured using radionuclide forearm venous plethysmography in 24 patients with CHF and 16 age-matched controls. The effect of basal NO activity on venous tone was assessed by infusing N-monomethyl-L-arginine 12 mg/min and stimulated NO using carbachol 15 mug/min. Brachial artery flow-mediated dilation was assessed by ultrasonic wall-tracking. RESULTS Blockade of basal NO release caused a significant and similar venoconstriction in patients (9.6 +/- 1.8%, p < 0.01) and controls (6.6 <plus/minus> 1.7%, p < 0.01). Carbachol-induced venodilation was significant and similar in patients (36.8 <plus/minus> 3.9%, p < 0.001) and controls (40.7 <plus/minus> 3.9%, p < 0.001). Brachial artery flow-mediated dilation was impaired in patients compared with controls (2.0 <plus/minus> 0.6% vs. 7.5 +/- 2.5%, p < 0.01). CONCLUSIONS Our data indicate that, despite marked impairment uf the function of the arterial endothelium, there is preservation of both basal and stimulated NO release in the forearm venous capacitance bed. This may provide important insights into mechanisms of endothelial dysfunction in CHF and thr potential for novel therapy. (J Am Coll Cardiol 2001;37:1062-8) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:1062 / 1068
页数:7
相关论文
共 41 条
[1]  
ABBOUD FM, 1976, CARDIOVASC PATHOL, P27
[2]   Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy [J].
Bäumer, AT ;
Flesch, M ;
Wang, XK ;
Shen, QC ;
Feuerstein, GZ ;
Böhm, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (01) :121-130
[3]  
BELCH JJF, 1991, BRIT HEART J, V65, P245
[4]   Investigation into the sources of superoxide in human blood vessels - Angiotensin II increases superoxide production in human internal mammary arteries [J].
Berry, C ;
Hamilton, CA ;
Brosnan, J ;
Magill, FG ;
Berg, GA ;
McMurray, JJV ;
Dominiczak, AF .
CIRCULATION, 2000, 101 (18) :2206-2212
[5]   Endothelium-derived nitric oxide contributes to the regulation of venous tone in humans [J].
Blackman, DJ ;
Morris-Thurgood, JA ;
Atherton, JJ ;
Ellis, GR ;
Anderson, RA ;
Cockcroft, JR ;
Frenneaux, MP .
CIRCULATION, 2000, 101 (02) :165-170
[6]   ACTIVATION OF SOLUBLE GUANYLATE-CYCLASE BY CARBON-MONOXIDE AND INHIBITION BY SUPEROXIDE ANION [J].
BRUNE, B ;
SCHMIDT, KU ;
ULLRICH, V .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 192 (03) :683-688
[7]  
CLELAND JGF, 1991, BRIT HEART J, V66, P264
[8]   RADIONUCLIDE EVALUATION OF PERIPHERAL CIRCULATORY DYNAMICS - NEW CLINICAL-APPLICATION OF BLOOD POOL SCINTIGRAPHY FOR MEASURING LIMB VENOUS VOLUME, CAPACITY, AND BLOOD-FLOW [J].
CLEMENTS, IP ;
STRELOW, DA ;
BECKER, GP ;
VLIETSTRA, RE ;
BROWN, ML .
AMERICAN HEART JOURNAL, 1981, 102 (06) :980-983
[9]  
COCKCROFT JR, 1995, J PHARMACOL EXP THER, V274, P1067
[10]   ENDOTHELIAL FUNCTION IN CHRONIC CONGESTIVE-HEART-FAILURE [J].
DREXLER, H ;
HAYOZ, D ;
MUNZEL, T ;
HORNIG, B ;
JUST, H ;
BRUNNER, HR ;
ZELIS, R .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (19) :1596-1601